--
Related Articles
Research
Research Alert: Canadian National Railway Posts Mixed Q1 Results As Eps Beats, Revenue Lags
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Canadian National Railway (CNR) posted Q1 adjusted EPS of CAD1.80, topping our CAD1.73 estimate but missing consensus CAD1.81, while revenue declined 1% to CAD4.38B as 3% volume growth was offset by 3% freight revenue per RTM decline from FX and carbon tax elimination impacts. Operating ratio deteriorated 80 bps to 64.2% as cost inflation offset revenue pressure, with the company delivered record Q1 operational performance including fuel efficiency up 3%, car velocity up 6%, and employee productivity up 8%. Mixed commercial results saw grain/fertilizers grow 10% while metals/minerals declined 11%, with free cash flow up 44% to CAD900M supporting CAD869M in share repurchases. Management reiterated expectations for flattish RTM growth in 2026 with EPS growth slightly exceeding volume growth amid heightened demand risk from macroeconomic volatility and trade tensions. We view the strong operational metrics and cash generation positively, though revenue headwinds and margin pressure remain near-term concerns.
$CNR
Research
Research Alert: Gehc Q1 2026: Solid Revenue Growth Amid Margin Pressures And Revised Outlook
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:GE HealthCare reported mixed Q1 2026 results with revenue of $5.1B, up 7.4% Y/Y (+2.9% organic), but adjusted EBIT margin contracted 150 bps to 13.5% due to operational challenges and inflationary pressures. Adjusted EPS of $0.99 declined modestly from $1.01 in the prior year, impacted by discrete PDx supplier issues, rising memory chip, oil, and freight costs, plus ongoing tariff impacts. Segment performance was mixed, in our view, with Pharmaceutical Diagnostics leading growth at +21.7% reported (+9.7% organic), while Patient Care Solutions declined -6.5% with EBIT margins contracting 500 bps to just 1.4%. Management reduced full-year adjusted EPS guidance to $4.80-$5.00 (from $4.95-$5.15) while maintaining organic revenue growth expectations of 3.0%-4.0%, which we view as achievable. The company expects to offset more than half of inflation impact through pricing and cost mitigation efforts, though margin pressures are expected to persist through 2026, given current challenging market conditions.
$GEHC
Research
Research Alert: Yum: Eps Beat On Taco Bell Strength And Kfc Expansion
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:YUM posted Q1 adjusted EPS of $1.50 (+15% Y/Y), beating the $1.39 consensus, while revenue reached $2.06B (+15% Y/Y), above the $2.04B consensus, on 3% global same-store sales and 4.6% net new store growth. Consolidated operating profit of $638M (+11%) beat the $622M consensus despite 110 bps margin contraction, as revenue growth offset cost pressures. We were impressed by strong same-store sales and unit growth pace; the highly franchised model (98% of stores) providing continued cost protection and capital efficiency. Management reiterated confidence in the long-term growth algorithm targeting 5% unit growth, 7% system sales growth ex-FX, and at least 8% core operating profit growth. Taco Bell delivered outstanding 8% same-store sales growth, outpacing broader QSR trends; KFC demonstrated strong global expansion with 7% unit growth and 70 bps margin expansion. Pizza Hut showed stabilization with flat same-store sales, but margins compressed 690 bps, reflecting ongoing category challenges.
$YUM